Wen Luo is the founder of Denovo Biopharma. Denovo Biopharma has raised $172M in total funding. Latest round: Series D. Backed by Yingke Capital.
Dr. Wen Luo is the founder, Chair, and CEO of Denovo Biopharma, a clinical-stage biopharmaceutical company based in San Diego. The company focuses on biomarker-driven precision medicines, and he leads the development of their precision medicine strategies.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide